Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
2022

Share:

Neurophet AQUA

Diagnostic solution

NEUROPHET, Inc.

NEUROPHET AQUA is a medical AI solution to diagnose dementia. AQUA helps doctors detect structural changes in the brain early before dementia occurs. That allows patients to receive appropriate treatment at the right time. Through AI algorithms, AQUA can detect quantitative changes in the brain that cannot be visualized in an MRI. Most medical solutions were slow, difficult, and complex. However, AQUA simplified and automated all these processes, significantly reducing the time users spend on analysis. This solution enables medical staff to diagnose dementia more efficiently and provide timely and adequate attention to patients.

Date of Launch
2021
Development Time
13 - 24 months
Target Regions
Asia, Australia / Oceania, Europe, North America
Target Groups
Consumer / User, Trade / Industry, Specific sub-group: Doctor, Medical staff, Senior patients

RELATED PROJECTS